These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors. McCluggage WG, McKenna M, McBride HA. Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419 [Abstract] [Full Text] [Related]
5. Ovarian sex cord-stromal tumours and their mimics. Young RH. Pathology; 2018 Jan; 50(1):5-15. PubMed ID: 29132723 [Abstract] [Full Text] [Related]
6. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases. Oliva E, Garcia-Miralles N, Vu Q, Young RH. Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484 [Abstract] [Full Text] [Related]
7. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Zhao C, Vinh TN, McManus K, Dabbs D, Barner R, Vang R. Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865 [Abstract] [Full Text] [Related]
12. Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors. Devouassoux-Shisheboran M, Deschildre C, Mauduit C, Berger G, Mejean-Lebreton F, Bouvier R, Droz JP, Fénichel P, Benahmed M. Oncol Rep; 2006 Aug; 16(2):335-40. PubMed ID: 16820912 [Abstract] [Full Text] [Related]
13. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Cathro HP, Stoler MH. Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297 [Abstract] [Full Text] [Related]
14. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases. Ordi J, Schammel DP, Rasekh L, Tavassoli FA. Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556 [Abstract] [Full Text] [Related]
15. Unclassified sex cord-stromal tumors of the ovary: a report of eight cases. Simpson JL, Michael H, Roth LM. Arch Pathol Lab Med; 1998 Jan; 122(1):52-5. PubMed ID: 9448017 [Abstract] [Full Text] [Related]
16. Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Rey R, Sabourin JC, Venara M, Long WQ, Jaubert F, Zeller WP, Duvillard P, Chemes H, Bidart JM. Hum Pathol; 2000 Oct; 31(10):1202-8. PubMed ID: 11070112 [Abstract] [Full Text] [Related]
17. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases. Zhao C, Bratthauer GL, Barner R, Vang R. Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771 [Abstract] [Full Text] [Related]
18. Microcystic stromal tumor of the ovary: report of 16 cases of a hitherto uncharacterized distinctive ovarian neoplasm. Irving JA, Young RH. Am J Surg Pathol; 2009 Mar; 33(3):367-75. PubMed ID: 18971779 [Abstract] [Full Text] [Related]
19. Uterine tumors resembling ovarian sex cord tumors: an update. Czernobilsky B. Int J Gynecol Pathol; 2008 Apr; 27(2):229-35. PubMed ID: 18317219 [Abstract] [Full Text] [Related]
20. Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors. Farinola MA, Gown AM, Judson K, Ronnett BM, Barry TS, Movahedi-Lankarani S, Vang R. Int J Gynecol Pathol; 2007 Oct; 26(4):375-82. PubMed ID: 17885486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]